A new study looking at the effectiveness of belimumab (Benlysta) as a treatment for people of Asian ethnicity living with lupus nephritis (LN) will address gaps in understanding using post-clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback